| Lateral hypothalamic orexin/hypocretin neurons: a role in reward-seeking and addiction G Aston-Jones, RJ Smith, GC Sartor, DE Moorman, L Massi, ... Brain research 1314, 74-90, 2010 | 465 | 2010 |
| Role of orexin/hypocretin in reward-seeking and addiction: implications for obesity AM Cason, RJ Smith, P Tahsili-Fahadan, DE Moorman, GC Sartor, ... Physiology & behavior 100 (5), 419-428, 2010 | 254 | 2010 |
| Multiple roles for orexin/hypocretin in addiction SV Mahler, RJ Smith, DE Moorman, GC Sartor, G Aston-Jones Progress in brain research 198, 79-121, 2012 | 243 | 2012 |
| Inhibition of HDAC3 reverses Alzheimer’s disease-related pathologies in vitro and in the 3xTg-AD mouse model KJ Janczura, CH Volmar, GC Sartor, SJ Rao, NR Ricciardi, G Lambert, ... Proceedings of the National Academy of Sciences 115 (47), E11148-E11157, 2018 | 161 | 2018 |
| A septal-hypothalamic pathway drives orexin neurons, which is necessary for conditioned cocaine preference GC Sartor, GS Aston-Jones Journal of Neuroscience 32 (13), 4623-4631, 2012 | 142 | 2012 |
| Epigenetic readers of lysine acetylation regulate cocaine-induced plasticity GC Sartor, SK Powell, SP Brothers, C Wahlestedt Journal of Neuroscience 35 (45), 15062-15072, 2015 | 76 | 2015 |
| The emerging role of non-coding RNAs in drug addiction GC Sartor, G St. Laurent III, C Wahlestedt Frontiers in genetics 3, 106, 2012 | 76 | 2012 |
| The BET-bromodomain inhibitor JQ1 reduces inflammation and tau phosphorylation at Ser396 in the brain of the 3xTg model of Alzheimer’s disease M Magistri, D Velmeshev, M Makhmutova, P Patel, G C Sartor, CH Volmar, ... Current Alzheimer Research 13 (9), 985-995, 2016 | 72 | 2016 |
| M344 promotes nonamyloidogenic amyloid precursor protein processing while normalizing Alzheimer’s disease genes and improving memory CH Volmar, H Salah-Uddin, KJ Janczura, P Halley, G Lambert, A Wodrich, ... Proceedings of the National Academy of Sciences 114 (43), E9135-E9144, 2017 | 58 | 2017 |
| Enhancement of BDNF expression and memory by HDAC inhibition requires BET bromodomain reader proteins GC Sartor, AM Malvezzi, A Kumar, NS Andrade, HJ Wiedner, SJ Vilca, ... Journal of Neuroscience 39 (4), 612-626, 2019 | 56 | 2019 |
| Post-retrieval extinction attenuates cocaine memories GC Sartor, G Aston-Jones Neuropsychopharmacology 39 (5), 1059-1065, 2014 | 56 | 2014 |
| Regulation of the ventral tegmental area by the bed nucleus of the stria terminalis is required for expression of cocaine preference GC Sartor, G Aston‐Jones European Journal of Neuroscience 36 (11), 3549-3558, 2012 | 56 | 2012 |
| Use of vivo-morpholinos for control of protein expression in the adult rat brain KJ Reissner, GC Sartor, EM Vazey, TE Dunn, G Aston-Jones, PW Kalivas Journal of neuroscience methods 203 (2), 354-360, 2012 | 55 | 2012 |
| Emerging, reemerging, and forgotten brain areas of the reward circuit: Notes from the 2010 Motivational Neural Networks conference VB McGinty, BY Hayden, SR Heilbronner, EC Dumont, SM Graves, ... Behavioural brain research 225 (1), 348-357, 2011 | 36 | 2011 |
| BET bromodomains as novel epigenetic targets for brain health and disease MB Singh, GC Sartor Neuropharmacology 181, 108306, 2020 | 32 | 2020 |
| The nociceptin/orphanin FQ receptor agonist SR-8993 as a candidate therapeutic for alcohol use disorders: validation in rat models AMA Aziz, S Brothers, G Sartor, L Holm, M Heilig, C Wahlestedt, ... Psychopharmacology 233, 3553-3563, 2016 | 32 | 2016 |
| Cocaine exposure increases blood pressure and aortic stiffness via the miR-30c-5p–malic enzyme 1–reactive oxygen species pathway W Zhu, H Wang, J Wei, GC Sartor, MM Bao, CT Pierce, CR Wahlestedt, ... Hypertension 71 (4), 752-760, 2018 | 25 | 2018 |
| Nanoparticle delivery systems for substance use disorder V Kasina, RJ Mownn, R Bahal, GC Sartor Neuropsychopharmacology 47 (8), 1431-1439, 2022 | 13 | 2022 |
| Nociceptin receptor activation does not alter acquisition, expression, extinction and reinstatement of conditioned cocaine preference in mice GC Sartor, SK Powell, HJ Wiedner, C Wahlestedt, SP Brothers brain research 1632, 34-41, 2016 | 12 | 2016 |
| Epigenetic pharmacotherapy for substance use disorder GC Sartor Biochemical pharmacology 168, 269-274, 2019 | 10 | 2019 |
